GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Cyclically Adjusted PS Ratio

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Cyclically Adjusted PS Ratio : 0.30 (As of May. 26, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Shanghai Pharmaceuticals Holding Co's current share price is ¥18.28. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥61.61. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio for today is 0.30.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:601607' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.26   Med: 0.47   Max: 1.05
Current: 0.3

During the past years, Shanghai Pharmaceuticals Holding Co's highest Cyclically Adjusted PS Ratio was 1.05. The lowest was 0.26. And the median was 0.47.

SHSE:601607's Cyclically Adjusted PS Ratio is ranked better than
57.58% of 66 companies
in the Medical Distribution industry
Industry Median: 0.385 vs SHSE:601607: 0.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥19.104. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥61.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.41 0.38 0.31 0.28

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.38 0.30 0.28 0.27

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio falls into.



Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=18.28/61.61
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=19.104/115.2271*115.2271
=19.104

Current CPI (Mar. 2024) = 115.2271.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 8.458 98.200 9.925
201409 9.186 98.900 10.702
201412 8.806 99.000 10.249
201503 9.344 99.900 10.778
201506 9.604 99.500 11.122
201509 10.447 100.500 11.978
201512 9.845 100.600 11.276
201603 10.889 102.200 12.277
201606 11.312 101.400 12.855
201609 11.462 102.400 12.898
201612 11.248 102.600 12.632
201703 12.322 103.200 13.758
201706 12.140 103.100 13.568
201709 12.365 104.100 13.687
201712 11.831 104.500 13.045
201803 13.038 105.300 14.267
201806 13.894 104.900 15.262
201809 14.768 106.600 15.963
201812 14.521 106.500 15.711
201903 16.338 107.700 17.480
201906 16.058 107.700 17.180
201909 16.840 109.800 17.672
201912 16.187 111.200 16.773
202003 14.417 112.300 14.793
202006 16.247 110.400 16.957
202009 18.802 111.700 19.396
202012 17.948 111.500 18.548
202103 18.253 112.662 18.669
202106 18.911 111.769 19.496
202109 19.548 112.215 20.073
202112 19.127 113.108 19.485
202203 20.012 114.335 20.168
202206 14.823 114.558 14.910
202209 18.399 115.339 18.381
202212 14.357 115.116 14.371
202303 17.891 115.116 17.908
202306 18.182 114.558 18.288
202309 17.512 115.339 17.495
202312 16.888 114.781 16.954
202403 19.104 115.227 19.104

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Ren Jian senior management
Liu Yan Jun senior management
Hu Feng Xiang Director
Zuo Min Director
Guo Jun Yu senior management
Han Min senior management
Lou Ding Bo Director
Chen Xin Supervisors
Shu Chang senior management
Li Yong Zhong senior management
Jiang Yuan Ying senior management
Xu Guo Xiong Director
Shen Bo senior management
Ge Jian Qiu senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines